Example: Heart Attack

Search clinical trials for: Didanosine

Total 151 results

NCT00668356

Suspended

Bioequivalence Study of Didanosine in Children Treated for HIV

Conditions: HIV Infections
NCT00002360

Completed

A Study Comparing Two Forms of Didanosine in HIV-infected Patients

Conditions: HIV Infections
NCT00000839

Completed

A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women

Conditions: HIV Infections; Pregnancy
NCT00000672

Completed

An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex

Conditions: HIV Infections
NCT00000669

Completed

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Conditions: HIV Infections
NCT00016718

Completed

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Conditions: HIV Infections
NCT00000963

Completed

A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine

Conditions: HIV Infections
NCT00002028

Completed

A Treatment IND (Investigational New Drug) Protocol for the Use of Videx (2',3'-Dideoxyinosine, ddI) in Patients With Acquired Immunodeficiency Syndrome (AIDS) or AIDS- Related Complex (ARC) Who Are Intolerant to Zidovudine (Retrovir)

Conditions: HIV Infections
NCT00008489

Unknown status

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

Conditions: HIV Infections
NCT00000710

Completed

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Conditions: HIV Infections
NCT00000656

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

Conditions: HIV Infections
NCT00002207

Completed

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

Conditions: HIV Infections
NCT00000652

Completed

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

Conditions: HIV Infections
NCT00000851

Completed

Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children

Conditions: HIV Infections
NCT00000823

Completed

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

Conditions: HIV Infections
NCT00000657

Completed

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Conditions: AIDS Dementia Complex; HIV Infections
NCT00002098

Completed

Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Conditions: HIV Infections
NCT00002099

Unknown status

Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive Patients

Conditions: HIV Infections
NCT00001049

Completed

A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

Conditions: HIV Infections
NCT00000772

Completed

A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals

Conditions: HIV Infections
NCT00002123

Completed

A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3

Conditions: HIV Infections
NCT00000833

Completed

A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.

Conditions: HIV Infections
NCT00256828

Completed

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Conditions: HIV Infections
NCT00000671

Completed

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

Conditions: HIV Infections
NCT00002274

Completed

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

Conditions: HIV Infections; Leukoencephalopathy, Progressive Multifocal